Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Rhythm Biosciences Ltd has successfully raised $3.5 million through a strong share placement, priced at $0.10 per share, to further develop and commercialize its ColoSTAT® Multiplex colorectal cancer test. The placement attracted significant interest from new institutional and sophisticated investors, reflecting confidence in the company’s innovative cancer diagnostics technology. The funds will support the finalization of the test kit, clinical validation, and expansion of their R&D pipeline.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.